What is Alpha Cognition Inc. Common Stock's (ACOG) StockRank?

MoatMap's StockRank for Alpha Cognition Inc. Common Stock (ACOG) is 34/100, with a Sell signal. This is a composite score combining Quality (34), Value (27), and Momentum (65) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Alpha Cognition Inc. Common Stock have an economic moat?

Alpha Cognition Inc. Common Stock (ACOG) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Alpha Cognition Inc. Common Stock a buy, hold, or sell?

MoatMap's current signal for Alpha Cognition Inc. Common Stock (ACOG) is Sell, based on a StockRank of 34/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Alpha Cognition Inc. Common Stock in?

Alpha Cognition Inc. Common Stock (ACOG) operates in the Healthcare sector, specifically the Biotechnology industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

ACOG

SellHot Air

Alpha Cognition Inc. Common Stock · Healthcare · United States · $199M · Avg Vol: $1M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-49.5%

D/E

0.0x

Dividend %

—

Dir. Trades · 180d

+$116.4K →

Subst. holders: +$4.2M

Buybacks · 180d

None →

COMPANY DESCRIPTION

Alpha Cognition Inc. is a biopharmaceutical company focused on developing novel diagnostic and therapeutic agents for neurodegenerative diseases, particularly Alzheimer's and ALS. It advances a proprietary diagnostic and therapeutic platform targeting specific biomarkers, aiming to provide earlier detection and more effective treatments for challenging neurological conditions. The company is a clinical-stage biotechnology firm specializing in neurodegenerative disorders, addressing significant unmet medical needs through innovative approaches.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	—	0	0	0	10.2M	—	15.3M	25.8M	—	152.3%
EPS	—	-0.56	-0.83	-2.04	-1.17	—	-0.96	-1.26	-0.62	—
Shares	—	21.8M	21.8M	16.0M	21.7M	-0.1%	21.8M	—	—	—
Debt	1.1M	1.2M	1.2M	0.9M	—	-5.4%	—	—	—	—
Equity	—	-1.3M	-4.7M	39.1M	62.5M	59.9%	—	—	—	—
Op CF	—	-9.2M	-8.8M	-7.8M	-20.4M	—	-30.9M	—	—	—
Inv CF	—	-4.9K	0	-26.7K	-0.3M	—	—	—	—	—
Fin CF	—	24.8K	8.2M	54.9M	38.2M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+1.9%

SMA 50SMA 200

$8.90

RSI (14)

39.6

52W High

$10.14

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

-38.3%20.1

ROE

-49.5%18.6

GP/Assets

17.3%39.1

Op. Margin

-127.3%15.7

FCF/Assets

-38.1%9.9

Piotroski

324.5

Int. Cover

—N/A

D/E Ratio

0.00x98.1

Current Ratio

9.03x85.6

Value

P/E (TTM)

—N/A

EV/EBITDA

-6.3x25.0

P/FCF

—N/A

P/B

3.9x37.0

P/S

13.6x21.5

Div Yield

—N/A

Momentum

52W High %

88%83.0

RS 6M

38%89.0

SMA 50/200

1.31x94.0

EPS Rev 4W

+1.6%61.6

EPS Rev 12W

-42.0%2.3

EPS Improve

+35%45.3

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$199M

P/E (Forward)

-15.4x

Gross Margin

90.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ACOG are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
ACOG	Alpha Cognition Inc. Common Stock(you)	$199M	34	Sell
ANTX	AN2 Therapeutics, Inc.	$211M	35	Sell
DTIL	Precision BioSciences, Inc.	$215M	28	Sell
WHWK	Whitehawk Therapeutics, Inc.	$263M	32	Sell
NAGE	Niagen Bioscience, Inc.	$260M	38	Hold
IMUX	Immunic, Inc.	$210M	26	Sell
NKTX	Nkarta, Inc.	$198M	22	Sell
EQ	Equillium, Inc.	$152M	27	Sell
OKUR	OnKure Therapeutics, Inc.	$153M	26	Sell
ABEO	Abeona Therapeutics Inc.	$339M	37	Hold

Peer medians: ROE -30.2% · P/E 27.0x · Gross margin 58.1%

Alpha Cognition Inc. Common Stock (ACOG): Stock Score Summary

Alpha Cognition Inc. Common Stock (ACOG) has a MoatMap StockRank of 34/100 based on Quality (34/100), Value (27/100), and Momentum (65/100) factor scores. The current signal is SELL.

Key Financial Metrics

Price	$8.90
Market Cap	$199M
P/E (Forward)	-15.35
Price/Book	3.91
Return on Equity	-49.5%
Return on Invested Capital	-38.3%
Debt/Equity	0.00x
Gross Margin	90.4%
Operating Margin	-127.3%
Revenue Growth	267.6%
Free Cash Flow	$-30M

Alpha Cognition Inc. Common Stock operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Alpha Cognition Inc. Common Stock’s (ACOG) StockRank?: MoatMap’s StockRank for Alpha Cognition Inc. Common Stock (ACOG) is 34/100, with a Sell signal. It is a composite of Quality (34), Value (27), and Momentum (65) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Alpha Cognition Inc. Common Stock have an economic moat?: Alpha Cognition Inc. Common Stock (ACOG) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Alpha Cognition Inc. Common Stock a buy, hold, or sell?: MoatMap’s current signal for Alpha Cognition Inc. Common Stock (ACOG) is Sell, based on a StockRank of 34/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Alpha Cognition Inc. Common Stock in?: Alpha Cognition Inc. Common Stock (ACOG) operates in the Healthcare sector, specifically the Biotechnology industry (United States).